(May 18 19:00) Forbes.com
We think that Centene stock (NYSE: CNC) currently is a better pick compared to the pharmaceuticals bellwether Johnson & Johnson stock (NYSE: JNJ), given Centene’s better prospects and comparatively lower valuation.
You can find the original article
here